Advanced pancreatic cancer remains one of the deadliest malignancies in 2022. Although there has been significant progress in treatment options with improved outcomes in many cancers, this growth has been slow in pancreatic cancer. This article examines specific components of approved first- and second-line therapies for advanced pancreatic cancer treatment and their effectiveness and concludes with a brief exploration of future directions for targeted therapies.
Keywords: Advanced pancreatic cancer treatment; Chemotherapy for pancreatic cancer; Metastatic pancreatic cancer.
Copyright © 2022 Elsevier Inc. All rights reserved.